CMPX vs JNPR · $367.4M cap vs P/E 38, $13.36B cap
Compass Therapeutics Inc. (CMPX) versus Juniper Networks Inc (JNPR) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Juniper Networks Inc (JNPR) is a communication equipment company listed on US.
CMPX does not have a complete income-statement cache yet.
JNPR does not have a complete income-statement cache yet.
CMPX currently screens at market cap $367.4M. JNPR currently screens at market cap $13.36B and trailing P/E 38.0.
Not investment advice. Open the CMPX and JNPR stock pages for the full models.
Not investment advice.